Defining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imaging

被引:23
|
作者
Duarte, Delfim [1 ,2 ,3 ,4 ]
Amarteifio, Saoirse [5 ]
Ang, Heather [1 ]
Kong, Isabella Y. [6 ,7 ]
Ruivo, Nicola [1 ]
Pruessner, Gunnar [5 ]
Hawkins, Edwin D. [1 ,6 ,7 ]
Lo Celso, Cristina [1 ,8 ]
机构
[1] Imperial Coll London, Dept Life Sci, Sir Alexander Fleming Bldg, London SW7 2AZ, England
[2] Univ Porto, i3S, P-4200135 Porto, Portugal
[3] Univ Porto, Fac Med, Dept Biomed, P-4200319 Porto, Portugal
[4] Portuguese Inst Oncol IPO Porto, Dept Oncohematol, P-4200072 Porto, Portugal
[5] Imperial Coll London, Dept Math, Huxley Bldg, London SW7 2AZ, England
[6] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia
[7] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia
[8] Francis Crick Inst, London WC2A 3LY, England
来源
IMMUNOLOGY AND CELL BIOLOGY | 2019年 / 97卷 / 02期
基金
欧洲研究理事会; 英国生物技术与生命科学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Acute myeloid leukemia cells; chemokines; intravital imaging; lymphoblastic leukemia; PLUS G-CSF; CXCR4; CHEMOTHERAPY; CHEMOSENSITIZATION; MOBILIZATION; INHIBITION; PROGENITOR;
D O I
10.1111/imcb.12216
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The majority of acute myeloid leukemia (AML) patients have a poor response to conventional chemotherapy. The survival of chemoresistant cells is thought to depend on leukemia-bone marrow (BM) microenvironment interactions, which are not well understood. The CXCL12/CXCR4 axis has been proposed to support AML growth but was not studied at the single AML cell level. We recently showed that T-cell acute lymphoblastic leukemia (T-ALL) cells are highly motile in the BM; however, the characteristics of AML cell migration within the BM remain undefined. Here, we characterize the in vivo migratory behavior of AML cells and their response to chemotherapy and CXCR4 antagonism, using high-resolution 2-photon and confocal intravital microscopy of mouse calvarium BM and the well-established MLL-AF9-driven AML mouse model. We used the Notch1-driven T-ALL model as a benchmark comparison and AMD3100 for CXCR4 antagonism experiments. We show that AML cells are migratory, and in contrast with T-ALL, chemoresistant AML cells become less motile. Moreover, and in contrast with T-ALL, the in vivo exploratory behavior of expanding and chemoresistant AML cells is unaffected by AMD3100. These results expand our understanding of AML cells-BM microenvironment interactions, highlighting unique traits of leukemia of different lineages.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 50 条
  • [21] Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications
    Long, Nathaniel A.
    Golla, Upendarrao
    Sharma, Arati
    Claxton, David F.
    STEM CELL REVIEWS AND REPORTS, 2022, 18 (04) : 1211 - 1226
  • [22] Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo
    Serhan, Nizar
    Mouchel, Pierre-Luc
    de Medina, Philippe
    Segala, Gregory
    Mougel, Aurelie
    Saland, Estelle
    Rives, Arnaud
    Lamaziere, Antonin
    Despres, Gaetan
    Sarry, Jean-Emmanuel
    Larrue, Clement
    Vergez, Francois
    Largeaud, Laetitia
    Record, Michel
    Recher, Christian
    Silvente-Poirot, Sandrine
    Poirot, Marc
    CANCERS, 2020, 12 (07) : 1 - 16
  • [23] Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia
    Corazza, F
    Hermans, C
    D'Hondt, S
    Ferster, A
    Kentos, A
    Benoît, Y
    Sariban, E
    BLOOD, 2006, 107 (06) : 2525 - 2530
  • [24] Defining the immune checkpoint landscape of acute myeloid leukemia (AML)
    Dever, Naval
    Basu, Sreyashi
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Ravandi, Farhad
    Kornblau, Steven
    Konopleva, Marina
    Andreeff, Michael
    Borthakur, Gautam
    Jain, Nitin
    Wierda, William
    Verstovsek, Srdan
    Ruvolo, Peter
    Kadia, Tapan
    Matthews, Jairo
    Flores, Wilmer
    Yang, Hui
    Bueso-Ramos, Carlos
    Somani, Narmeen
    Blando, Jorge
    Allison, James
    Kantarjian, Hagop
    Sharma, Padmanee
    CANCER RESEARCH, 2016, 76
  • [25] DEFINING FRAILTY OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AT DIAGNOSIS
    Aydin, S.
    Audisio, E.
    D'Ardia, S.
    Allione, B.
    Nicolino, B.
    Busca, A.
    Dellacasa, C. M.
    Evangelista, A.
    Ciccone, G.
    Vitolo, U.
    HAEMATOLOGICA, 2016, 101 : 384 - 385
  • [26] Defining Patient-Specific Risk in Acute Myeloid Leukemia
    Ho, Tzu-Chieh
    Becker, Michael W.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) : 3857 - 3859
  • [27] Human mesenchymal stem cells enhances the growth of acute myeloid leukemia cells in vivo.
    Cen, JN
    Chen, ZX
    Qian, J
    Li, ZJ
    Qiu, QC
    BLOOD, 2005, 106 (11) : 649A - 649A
  • [28] Acute myeloid leukemia stem cells
    Dick, JE
    HEMATOPOIETIC STEM CELLS V, 2005, 1044 : 1 - 5
  • [29] THE CLINICAL-SIGNIFICANCE OF BIOLOGICAL CHARACTERISTICS OF THE CELLS IN ACUTE MYELOID-LEUKEMIA
    BAER, MR
    BLOOMFIELD, CD
    ANNUAL REVIEW OF MEDICINE, 1991, 42 : 381 - 389
  • [30] PROGNOSTIC VALUE OF IMMUNOPHENOTYPIC CHARACTERISTICS OF BLAST CELLS IN ACUTE MYELOID-LEUKEMIA
    LANZA, F
    RIGOLIN, GM
    MORETTI, S
    LATORRACA, A
    CASTOLDI, G
    LEUKEMIA & LYMPHOMA, 1994, 13 : 81 - 85